Fidelity Investments Portfolio holdings
Fidelity Investments, founded in 1946 by Edward C. Johnson II and headquartered in Boston, Massachusetts, is one of the largest privately-held financial services firms in the world, managing hundreds of billions in assets. Known for its wide array of investment products, including mutual funds, retirement accounts, brokerage services, and wealth management, Fidelity caters to both individual investors and institutions with a reputation for strong customer service and innovative tools like its active trader platforms. The company pioneered direct-to-investor mutual fund sales, bypassing traditional brokers, and has since expanded into areas like cryptocurrency trading and commission-free stock trades. Still family-controlled by the Johnson family, Fidelity blends a legacy of traditional investing with a forward-looking approach to technology and market trends.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Boeing
BA
|
+$1.92B |
| 2 |
Coherent
COHR
|
+$1.61B |
| 3 |
Western Digital
WDC
|
+$1.52B |
| 4 |
Tesla
TSLA
|
+$1.5B |
| 5 |
Eli Lilly
LLY
|
+$1.48B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$5.11B |
| 2 |
Microsoft
MSFT
|
+$4.78B |
| 3 |
TSMC
TSM
|
+$3.54B |
| 4 |
Uber
UBER
|
+$2.65B |
| 5 |
NVIDIA
NVDA
|
+$2.17B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 32.74% |
| 2 | Communication Services | 12.46% |
| 3 | Financials | 11.63% |
| 4 | Consumer Discretionary | 9.74% |
| 5 | Healthcare | 9.31% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
826
NovaGold Resources
NG
$3.4B
| $223M | 0.01% |
23,912,548
+6,990,189
| +41% | +$64.8M |
|
827
Illumina
ILMN
$29.1B
| $222M | 0.01% |
1,694,354
+123,631
| +8% | +$14.5M |
|
828
TTM Technologies
TTMI
$14.6B
| $222M | 0.01% |
3,212,632
+210,260
| +7% | +$13.7M |
|
|
FFUT
829
Fidelity Managed Futures ETF
FFUT
$335M
| $220M | 0.01% |
4,125,965
+1,810,060
| +78% | +$96.5M |
|
|
ORKA
830
Oruka Therapeutics
ORKA
$7.16B
| $220M | 0.01% |
7,261,384
+3,763
| +0.1% | +$105K |
|
831
Wolverine World Wide
WWW
$1.63B
| $220M | 0.01% |
12,110,159
+1,864,825
| +18% | +$37.7M |
|
832
Ball Corp
BALL
$16.4B
| $220M | 0.01% |
4,145,082
-1,086,023
| -21% | -$53.4M |
|
833
Nordson
NDSN
$17.3B
| $219M | 0.01% |
912,558
+22,105
| +2% | +$5.19M |
|
834
Western Alliance Bancorporation
WAL
$8.92B
| $219M | 0.01% |
2,605,488
-328,200
| -11% | -$26.7M |
|
835
EQT Corp
EQT
$33.8B
| $218M | 0.01% |
4,058,948
+1,221,556
| +43% | +$68.6M |
|
836
NatWest
NWG
$76.9B
| $217M | 0.01% |
12,420,005
+2,967,824
| +31% | +$47M |
|
837
NovoCure
NVCR
$2.02B
| $217M | 0.01% |
16,796,979
+27,101
| +0.2% | +$348K |
|
838
Reliance Steel & Aluminium
RS
$21.7B
| $217M | 0.01% |
749,716
+40,849
| +6% | +$11.5M |
|
839
Barclays
BCS
$94.6B
| $217M | 0.01% |
8,509,639
+957,591
| +13% | +$21.2M |
|
840
Axsome Therapeutics
AXSM
$11.2B
| $216M | 0.01% |
1,181,622
+253,739
| +27% | +$35.4M |
|
|
RAPP
841
Rapport Therapeutics
RAPP
$2.27B
| $216M | 0.01% |
7,111,865
+194,870
| +3% | +$5.39M |
|
842
Saic
SAIC
$5.35B
| $215M | 0.01% |
2,138,413
-860,151
| -29% | -$82.1M |
|
843
iShares Broad USD High Yield Corporate Bond ETF
USHY
$29.2B
| $215M | 0.01% |
5,745,828
+15,806
| +0.3% | +$592K |
|
844
AXIS Capital
AXS
$7.3B
| $211M | 0.01% |
1,974,209
+265,671
| +16% | +$26.4M |
|
|
CADE
845
DELISTED
Cadence Bank
CADE
| $211M | 0.01% |
4,927,404
-3,135,476
| -39% | -$124M |
|
846
Mohawk Industries
MHK
$9.42B
| $210M | 0.01% |
1,925,714
-155,364
| -7% | -$17.8M |
|
847
iShares MSCI EAFE Small-Cap ETF
SCZ
$13.6B
| $210M | 0.01% |
2,711,858
-47,300
| -2% | -$3.63M |
|
848
Quest Diagnostics
DGX
$26.1B
| $209M | 0.01% |
1,202,254
-11,118
| -0.9% | -$2.02M |
|
849
BOK Financial
BOKF
$8.85B
| $206M | 0.01% |
1,742,924
+350,344
| +25% | +$39.3M |
|
850
Eaton Vance Total Return Bond ETF
EVTR
$5.74B
| $205M | 0.01% |
3,982,015
+541,807
| +16% | +$28M |
|
Similar funds
Fidelity Investments's Q4 2025 Portfolio in Review
As of Q4 2025, Fidelity Investments held 5,671 positions worth $1.96T, up 2% from $1.92T the previous quarter. Its ten largest holdings account for 36% of the portfolio.
Fidelity Investments's Q4 2025 filing shows 288 new, 2,878 increased, 1,747 reduced and 258 closed positions. Its largest new stake was Medline Inc: 26,354,214 shares worth $1.11B. The largest sale was Meta Platforms (Facebook), an estimated $5.11B.
By sector, the portfolio is most concentrated in Technology at 33% of assets, down from 33% a quarter earlier, followed by Communication Services and Financials.
- Fidelity Investments's largest Q4 2025 buy was Medline Inc: 26,354,214 shares worth $1.11B.
- Fidelity Investments added most to Boeing in Q4 2025, an estimated $1.92B increase.
- Fidelity Investments's biggest Q4 2025 reduction was Meta Platforms (Facebook), cutting an estimated $5.11B.
- Fidelity Investments fully exited Metsera Inc in Q4 2025, selling an estimated $727M.
- Fidelity Investments's ten largest holdings make up 36% of its $1.96T portfolio in Q4 2025.
- Fidelity Investments opened 288 new positions and closed 258 in Q4 2025.
- Fidelity Investments's portfolio value rose 2% quarter-over-quarter to $1.96T.
Based on Fidelity Investments's 13F filing for Q4 2025, filed 17 Feb 2026.